iss 1018 cpg oligodeoxynucleotide
iss 1018 cpg oligodeoxynucleotide: sourced relationships with 1 company · 2 clinical trials tracked.
iss 1018 cpg oligodeoxynucleotide evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could iss 1018 cpg oligodeoxynucleotide → DVAX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Shingles | Approved |
Clinical Trial Registry Records (2)
A Phase 1 Double-blind, Randomized, Dose Finding Clinical Trial With an Open-label run-in Part to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Flavivirus-naïve Adults Aged 18 to 49 Years
Primary endpoint: Solicited Adverse Events
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Aalum Adjuvants and VRC HIV Env Trimer 4571 and 3M-052-AF With Alum in Healthy, HIV-uninfected Adults
Primary endpoint: Number of Participants Reporting Local Solicited Adverse Events Signs and Symptoms: Pain and/or Tenderness
Frequently asked questions
Which companies have sourced relationships with iss 1018 cpg oligodeoxynucleotide?
iss 1018 cpg oligodeoxynucleotide has dated SEC/FDA relationship records for DYNAVAX TECHNOLOGIES CORP.
How many clinical trials involve iss 1018 cpg oligodeoxynucleotide?
BioSniper tracks 2 clinical trials involving iss 1018 cpg oligodeoxynucleotide.